GB201020191D0 - Glucan gels - Google Patents

Glucan gels

Info

Publication number
GB201020191D0
GB201020191D0 GBGB1020191.1A GB201020191A GB201020191D0 GB 201020191 D0 GB201020191 D0 GB 201020191D0 GB 201020191 A GB201020191 A GB 201020191A GB 201020191 D0 GB201020191 D0 GB 201020191D0
Authority
GB
United Kingdom
Prior art keywords
glucan
mol
concentration
aqueous solution
weight average
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1020191.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arcticzymes Technologies ASA
Original Assignee
Biotec Pharmacon ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Pharmacon ASA filed Critical Biotec Pharmacon ASA
Priority to GBGB1020191.1A priority Critical patent/GB201020191D0/en
Publication of GB201020191D0 publication Critical patent/GB201020191D0/en
Priority to KR1020137016831A priority patent/KR20130121138A/ko
Priority to CA2818648A priority patent/CA2818648C/en
Priority to CN201180056825.XA priority patent/CN103347899B/zh
Priority to US13/989,594 priority patent/US9314432B2/en
Priority to PCT/GB2011/052358 priority patent/WO2012073019A1/en
Priority to EP11796784.4A priority patent/EP2646476B1/en
Priority to JP2013540442A priority patent/JP5932825B2/ja
Priority to US15/066,748 priority patent/US9750688B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
GBGB1020191.1A 2010-11-29 2010-11-29 Glucan gels Ceased GB201020191D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB1020191.1A GB201020191D0 (en) 2010-11-29 2010-11-29 Glucan gels
KR1020137016831A KR20130121138A (ko) 2010-11-29 2011-11-29 글루칸 겔
CA2818648A CA2818648C (en) 2010-11-29 2011-11-29 Glucan gels
CN201180056825.XA CN103347899B (zh) 2010-11-29 2011-11-29 葡聚糖凝胶
US13/989,594 US9314432B2 (en) 2010-11-29 2011-11-29 Glucan gels
PCT/GB2011/052358 WO2012073019A1 (en) 2010-11-29 2011-11-29 Glucan gels
EP11796784.4A EP2646476B1 (en) 2010-11-29 2011-11-29 Glucan gels
JP2013540442A JP5932825B2 (ja) 2010-11-29 2011-11-29 グルカンゲル
US15/066,748 US9750688B2 (en) 2010-11-29 2016-03-10 Glucan gels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1020191.1A GB201020191D0 (en) 2010-11-29 2010-11-29 Glucan gels

Publications (1)

Publication Number Publication Date
GB201020191D0 true GB201020191D0 (en) 2011-01-12

Family

ID=43500783

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1020191.1A Ceased GB201020191D0 (en) 2010-11-29 2010-11-29 Glucan gels

Country Status (8)

Country Link
US (2) US9314432B2 (enExample)
EP (1) EP2646476B1 (enExample)
JP (1) JP5932825B2 (enExample)
KR (1) KR20130121138A (enExample)
CN (1) CN103347899B (enExample)
CA (1) CA2818648C (enExample)
GB (1) GB201020191D0 (enExample)
WO (1) WO2012073019A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT514137A1 (de) 2013-04-05 2014-10-15 Lenzing Akiengesellschaft Polysaccharidfaser und Verfahren zu ihrer Herstellung
AT514468A1 (de) 2013-06-17 2015-01-15 Lenzing Akiengesellschaft Hochsaugfähige Polysaccharidfaser und ihre Verwendung
AT514474B1 (de) 2013-06-18 2016-02-15 Chemiefaser Lenzing Ag Polysaccharidfaser und Verfahren zu ihrer Herstellung
AT518612B1 (de) 2015-02-06 2019-03-15 Chemiefaser Lenzing Ag Polysaccharid-Suspension, Verfahren zu ihrer Herstellung und ihre Verwendung
CN112402443B (zh) * 2019-08-22 2024-12-31 广州立恩生物科技有限公司 用于预防和治疗口腔疾病的生物多糖及其应用
CN111329875B (zh) * 2020-02-26 2023-07-21 好维股份有限公司 用于修复口腔软组织细胞的口腔护理组合物及应用
US11572420B1 (en) 2021-07-30 2023-02-07 Tissue repair ltd Isolated biological polysaccharide compound, methods of use and methods of manufacture thereof
US11384160B1 (en) 2021-07-30 2022-07-12 Tissue repair ltd Method of making a beta glucan compound
CN116239706B (zh) * 2022-10-24 2024-06-21 湖北中医药大学 一种直链茯苓β-葡聚糖及其提取方法和应用
CN116584552B (zh) * 2023-05-19 2024-03-26 江南大学 一种基于葡聚糖自主装交联多维度乳液凝胶的制备及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503952A (ja) 1989-09-08 1993-06-24 アルファ　ベータ　テクノロジー，インコーポレイティッド 可溶性グルカン類の製造方法
US5158772A (en) * 1991-09-23 1992-10-27 Davis Walter B Unique bacterial polysaccharide polymer gel in cosmetics, pharmaceuticals and foods
NO300692B1 (no) 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US5980918A (en) 1997-10-24 1999-11-09 Brennen Medical, Inc. β-D-glucan topical composition
US6875754B1 (en) 1999-03-12 2005-04-05 Biotec Asa Use of water-soluble β-(1,3) glucans as agents for producing therapeutic skin treatment agents
AU2001282708B2 (en) * 2000-07-03 2007-01-04 Granate Seed Limited Cold water soluble beta-glucan product and process for preparing the same
EP1357919B1 (en) 2001-01-16 2017-04-05 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
GB0225502D0 (en) 2002-11-01 2002-12-11 Zoolife Internat Ltd Therapeutic and prophylactic preparations
CN101394898A (zh) * 2005-11-30 2009-03-25 西巴控股公司 葡聚糖组合物
US8323644B2 (en) * 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
CN101426510A (zh) * 2006-01-17 2009-05-06 斯隆-凯特林癌症研究院 增强治疗的酵母葡聚糖
WO2008102151A1 (en) 2007-02-21 2008-08-28 Biotec Pharmacon Asa Medical uses of glucans
JP2011503161A (ja) * 2007-11-13 2011-01-27 バイオテック・ファルマコン・アーエスアー 腸管の炎症性疾患を処置または予防する方法
CN101353383B (zh) * 2008-09-17 2010-12-08 山东京博控股发展有限公司 水溶性酵母β-葡聚糖及其制备方法

Also Published As

Publication number Publication date
EP2646476B1 (en) 2017-01-25
US9750688B2 (en) 2017-09-05
JP5932825B2 (ja) 2016-06-08
WO2012073019A1 (en) 2012-06-07
CA2818648C (en) 2016-11-15
CN103347899B (zh) 2016-08-17
KR20130121138A (ko) 2013-11-05
CN103347899A (zh) 2013-10-09
EP2646476A1 (en) 2013-10-09
JP2013544937A (ja) 2013-12-19
US20130315979A1 (en) 2013-11-28
US20160256385A1 (en) 2016-09-08
US9314432B2 (en) 2016-04-19
CA2818648A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
GB201020191D0 (en) Glucan gels
GB201020190D0 (en) Glucans
RU2013129785A (ru) Интерполимерный сшитый гель и способ использования
BR112013001235A2 (pt) processo para alisamento semipermanente de cabelos cacheados, crespos ou ondulados
PH12012502352A1 (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
NO20055721D0 (no) A method of sol-gel processing
WO2008063842A3 (en) Methods of treating neuropathic pain with agonists of ppar-gamma
EA201500485A1 (ru) Длинные растворимые полипептиды ph20 и их использование
WO2012087823A3 (en) Ph-induced silk fibroin gels and uses thereof
ATE536192T1 (de) Vernetzte hyaluronsäure und kollagen und ihre verwendungen
MX2020003168A (es) Pirimidinas modificadas en la posicion 5 y su uso.
MX370903B (es) Composiciones de ácido percarboxílico estables y sus usos.
EP2418945A4 (en) Mineral salt-sulfuric acid compositions and methods for their use
MX2011009127A (es) Nicotinamidas sustituidas como moduladores de kcnq2/3.
PH12014501556A1 (en) Microorganism able to produce l-amino acid, and method for producing l-amino acid by using same
GB2514737A (en) Dual responsive block copolymer compositions
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
UA106080C2 (uk) Незлежувана композиція хлориду натрію, спосіб її одержання і застосування
BR112014018051A8 (pt) Processo para preparação de sílicas precipitadas
BR112013028607A2 (pt) composições sólidas contendo éter glicólico e água
EP2540700A4 (en) STABLE Aqueous ACRYLAMIDE SOLUTION
NZ613554A (en) Caprylate viral deactivation
IT1394383B1 (it) Procedimento e dispositivo per la preparazione del sale sodico dell'acido desossiribonucleico , e relativo prodotto.
UA107155C2 (uk) Стабільна композиція для лікування герпесвірусних інфекцій
EA201201518A1 (ru) Способ получения па-410 и па-410, получаемый таким способом

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)